Nordic Bioscience landing a multi-million deal with Danish pharmaceutical

A multi-million deal in Denmark

Nordic Bioscience has established yet another collaboration with a large Danish pharmaceutical company. In the context of this multi-million deal, we provide clinical laboratory services for safety testing requiring exceptional speed, flexibility, and customized electronic data delivery.

Safety studies are simply unavoidable before a drug candidate can be rolled out on the market. At the same time, Nordic Bioscience is the only CAP-certified lab in Scandinavia that can assist in regulatory decision-making by assessing the safety and benefit-risk profile of a drug. Our laboratory provides full central laboratory services for clinical development.

Get in touch

Are you interested in exploring collaboration possibilities?
Enter your information in the form and a representative will contact you shortly.